why choose us

First received: October 04, 2023

Clinical Trial: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Liver Transplant

Study Type: INTERVENTIONAL


Official Title: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (CTOT-44)

Brief Summary: This is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of Cytomegalovirus-Modified Vaccinia Ankara (CMV-MVA) Triplex CMV vaccine pre-transplant.The primary objective is to assess the effect of pre-transplant (Tx) Triplex vaccination on duration of CMV antiviral therapy (AVT) within the first 100 days post-Tx in CMV seronegative (R-) and seropositive donor (D+) (D+R-) liver transplant recipients (LTxRs).A…

Read more